Abstract
High-density lipoproteins (HDL) have antiinflammatory effects on the vascular endothelium. Because bone morphogenetic proteins (BMPs) are known to be inflammatory mediators, we examined the effect of HDL on BMP signaling. Increasing concentrations of HDL progressively enhanced expression of the activin-like kinase receptor (ALK)1 and ALK2 in human aortic endothelial cells as determined by real-time polymerase chain reaction and immunoblotting. Induction of ALK1 was a result of enhanced ALK2 expression as determined by siRNA interference, and was associated with increased levels of vascular endothelial growth factor (VEGF) and matrix Gla protein (MGP). The HDL-induction of ALK2 was dependent on BMP-signaling, and affected coregulation of the ALK2 gene by the homeodomain proteins MSX2, DLX3, and DLX5, as determined by reporter gene assays, siRNA interference, and chromatin immunoprecipitation. Apolipoprotein A-I transgenic mice, known to have high HDL and inhibition of atherogenesis, exhibited similar changes in aortic gene expression as seen in endothelial cells treated with HDL in vitro. We conclude that HDL benefits the arterial wall by allowing for enhanced ALK1 and ALK2 signaling, resulting in an increase of VEGF and MGP, essential for endothelial cell survival and prevention of vascular calcification, respectively.
MeSH Terms
Activin Receptors, Type I/genetics,metabolism
Activin Receptors, Type II/genetics,metabolism
Animals
Apolipoprotein A-I/genetics
Atherosclerosis/etiology,genetics,metabolism,prevention & control
Base Sequence
Bone Morphogenetic Protein 4/metabolism,pharmacology
Bone Morphogenetic Proteins/metabolism
Calcium-Binding Proteins/metabolism
Cattle
Cells, Cultured
Endothelial Cells/drug effects,metabolism
Extracellular Matrix Proteins/metabolism
Humans
Lipoproteins, HDL/metabolism,pharmacology
Mice
Mice, Inbred C57BL
Mice, Transgenic
Promoter Regions, Genetic
RNA Interference
RNA, Small Interfering/genetics
Signal Transduction/drug effects
Vascular Endothelial Growth Factor A/metabolism
Chemicals
Apolipoprotein A-I
BMP4 protein, human
Bone Morphogenetic Protein 4
Bone Morphogenetic Proteins
Calcium-Binding Proteins
Extracellular Matrix Proteins
Lipoproteins, HDL
RNA, Small Interfering
VEGFA protein, human
Vascular Endothelial Growth Factor A
matrix Gla protein
ACVR1 protein, human
ACVRL1 protein, human
Activin Receptors, Type I
Activin Receptors, Type II
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Yao Yucheng
Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA.
Shao Esther S
Jumabay Medet
Shahbazian Ani
Ji Sheng
Boström Kristina I
References (31)
31 references, click to expand
-
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques.
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1998-2003
PMID: 11742876
-
Evaluation of cardiovascular risk factors and bone mineral density in post menopausal women undergoing coronary angiography.
Int J Cardiol. 2008 Dec 17;131(1):66-9
PMID: 18222554
-
Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response.
J Biol Chem. 2003 Aug 15;278(33):31128-35
PMID: 12766166
-
Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?
Endocrine. 2004 Feb;23(1):1-10
PMID: 15034190
-
Cardiac outflow tract defects in mice lacking ALK2 in neural crest cells.
Development. 2004 Jul;131(14):3481-90
PMID: 15226263
-
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
Nature. 1991 Sep 19;353(6341):265-7
PMID: 1910153
-
Bone morphogenetic protein expression in human atherosclerotic lesions.
J Clin Invest. 1993 Apr;91(4):1800-9
PMID: 8473518
-
Immunolocalization of BMP-6, a novel TGF-beta-related cytokine, in normal and atherosclerotic smooth muscle cells.
Atherosclerosis. 1995 Mar;113(2):153-6
PMID: 7605353
-
High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells.
Circulation. 2005 May 31;111(21):2805-11
PMID: 15911702
-
Bone morphogenetic proteins in vascular calcification.
Circ Res. 2005 Jul 22;97(2):105-14
PMID: 16037577
-
Lipid levels and bone mineral density.
Am J Med. 2005 Dec;118(12):1414
PMID: 16378789
-
Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype.
Am J Pathol. 2006 Feb;168(2):629-38
PMID: 16436676
-
Endothelial and antithrombotic actions of HDL.
Circ Res. 2006 Jun 9;98(11):1352-64
PMID: 16763172
-
Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling.
Mol Cell Biol. 2006 Oct;26(20):7791-805
PMID: 16923969
-
Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1.
J Biol Chem. 2006 Nov 10;281(45):33921-30
PMID: 16950789
-
The new bone biology: pathologic, molecular, and clinical correlates.
Am J Med Genet A. 2006 Dec 1;140(23):2646-706
PMID: 17103447
-
BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network.
J Biol Chem. 2006 Dec 29;281(52):40515-26
PMID: 17060321
-
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
Blood. 2007 Mar 1;109(5):1953-61
PMID: 17068149
-
Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium.
Vasc Health Risk Manag. 2005;1(2):119-29
PMID: 17315398
-
BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
J Cell Sci. 2007 Mar 15;120(Pt 6):964-72
PMID: 17311849
-
Activin-like kinase receptor 1 (ALK1) in atherosclerotic lesions and vascular mesenchymal cells.
Cardiovasc Res. 2007 May 1;74(2):279-89
PMID: 17074310
-
High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory.
Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1346-53
PMID: 17379837
-
Autocrine VEGF signaling is required for vascular homeostasis.
Cell. 2007 Aug 24;130(4):691-703
PMID: 17719546
-
Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis.
Circulation. 2007 Sep 11;116(11):1258-66
PMID: 17785623
-
Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment.
Can J Physiol Pharmacol. 2007 Aug;85(8):767-73
PMID: 17901886
-
Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice.
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2589-96
PMID: 17932314
-
Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial.
J Clin Endocrinol Metab. 2007 Dec;92(12):4671-7
PMID: 17726081
-
Cholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors.
J Cell Physiol. 2008 Apr;215(1):223-33
PMID: 17972267
-
Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4.
Circ Res. 2008 May 9;102(9):1065-74
PMID: 18369157
-
Novel homeobox genes are differentially expressed in placental microvascular endothelial cells compared with macrovascular cells.
Placenta. 2008 Jul;29(7):624-30
PMID: 18514308
-
Mechanisms of TGF-beta signaling from cell membrane to the nucleus.
Cell. 2003 Jun 13;113(6):685-700
PMID: 12809600